Research > ETFs > ETF / ETP Commentary > 

Best & Worst Monthly Performers: May 5 Edition

Here is a look at the 25 best and 25 worst ETFs from the past trading month. Traders can use this list to find prospective candidates that have deviated too far from their longer-term trends, thereby serving as potential starting points for those looking to take on either short or long positions.Likewise, traders can also use this list to spot potential trend reversal opportunities that may offer a generous risk/reward. As always, investors of all experience levels are advised to use stop-loss orders and practice disciplined profit-taking techniques.To‌ ‌get‌ ‌access‌ ‌to‌ ‌all‌ ‌ETFdb.com‌ ‌premium‌ ‌content,‌ ‌sign‌ ‌up‌ ‌for‌ ‌a free‌ ‌14-day‌ ‌trial‌ ‌to‌ ‌ETFdb.com‌ ‌Pro.Best-Performing ETFsU.S. market indices gained on the successful rollout of COVID-19 vaccines, support from the U.S. government, and expectations of an economic rebound.The Breakwave Dry Bulk Shipping ETF (BDRY) topped this month’s best monthly performers list on favorable dry shipping fundamentals and improving global economic growth.Elements MLCX Grains ETN (GRU B), Teucrium Corn Fund (CORN B), and Teucrium Wheat Fund (WEAT C) ranked high on the best-performing ETFs list, returning over 21%, 19%, and 18% respectively. In the last month, grain prices have risen on weather concerns. Check out our list of agricultural commodities here.Many metals focusing ETFs such as the Aberdeen Standard Physical Palladium Shares ETF (PALL A), Global X Copper Miners ETF (COPX B), Sprott Physical Platinum and Palladium Trust SPPP, and iShares MSCI Global Metals & Mining Producers ETF (PICK A-) ranked amidst the best-performing ETFs as the metals and mining sector gained by more than 8% in the last month.Several Brazilian ETFs like the iShares MSCI Brazil Small-Cap ETF (EWZS A-), First Trust Brazil AlphaDEX Fund (FBZ C), and VanEck Vectors Brazil Small-Cap ETF (BRF A-) featured on the list as Brazil’s market soared after the Brazilian unit of the world’s largest crop trader, Cargill, posted better-than-expected results driven by optimism around agricultural commodities.ETFMG Treatments Testing and Advancements ETF (GERM), launched in June of last year and tracking the performance of U.S. companies engaged in R&D, vaccines, therapies, and testing technologies, also made it to the list of best performers, as it is well-positioned to gain from the Novavax vaccine receiving a potential U.S. approval.To compare this month’s list with the one published on April 7, click here.Worst-Performing ETFsSeveral volatility ETFs like the ProShares VIX Short-Term Futures ETF (VIXY A) and iPath S&P 500 VIX Short-Term Futures ETN (VXX B+) topped this month’s worst-performing ETFs list as volatility declined in the last month. VIX, the CBOE Volatility index continues to linger near the 17-mark. Other volatility ETFs like the iPath S&P 500 VIX Mid-Term Futures ETN (VXZ B) and ProShares VIX Mid-Term Futures ETF (VIXM A+) also made it to the list. Here is our list of volatility ETFs.Many Japanese ETFs like the WisdomTree Japan Hedged SmallCap Equity Fund (DXJS A-), WisdomTree Japan SmallCap Dividend Fund (DFJ B), and iShares MSCI Japan Value ETF (EWJV) ranked amidst the worst-performing ETFs list as coronavirus cases surged in the country. You can browse the complete list of Japanese ETFs here.Several marijuana ETFs, such as the AdvisorShares Pure Cannabis ETF (YOLO), Global X Cannabis ETF (POTX), and Cambria Cannabis ETF (TOKE) featured on the worst-performing ETFs list on worse-than-expected quarterly earnings results by Aphria.Columbia India Consumer ETF (INCO C), which tracks an index comprising 30 Indian consumer stocks, was one of the worst-performing ETFs this month as India has been devastated by a second wave of coronavirus infections.Please note that this list is updated on a monthly basis.For more ETF analysis, make sure to sign up for our free ETF newsletter.Disclosure: No positions at time of writing.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.